npj Vaccines
(Feb 2024)
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report
Milton Maciel,
Rama R. Amara,
Katharine J. Bar,
Shane Crotty,
Steven G. Deeks,
Christopher Duplessis,
Gaurav Gaiha,
M. Juliana McElrath,
Andrew McMichael,
Amy Palin,
Rachel Rutishauser,
Stuart Shapiro,
Stephen T. Smiley,
M. Patricia D’Souza
Affiliations
Milton Maciel
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rama R. Amara
Yerkes National Primate Research Center, Emory University
Katharine J. Bar
Department of Medicine, University of Pennsylvania
Shane Crotty
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Steven G. Deeks
Department of Medicine, University of California at San Francisco
Christopher Duplessis
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Gaurav Gaiha
Ragon Institute of Mass General, MIT and Harvard
M. Juliana McElrath
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Andrew McMichael
Nuffield Department of Clinical Medicine, University of Oxford
Amy Palin
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rachel Rutishauser
Department of Medicine, University of California
Stuart Shapiro
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Stephen T. Smiley
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
M. Patricia D’Souza
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
DOI
https://doi.org/10.1038/s41541-024-00818-y
Journal volume & issue
Vol. 9,
no. 1
pp.
1
– 6
Abstract
Read online
The US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), convened a virtual workshop on August 8-9th, 2023 to explore potential synergies between HIV vaccine approaches that are designed to induce cellular or humoral immune responses. The goal of this workshop was to review data on leading vaccine candidates and to discuss the best strategies for combining these approaches to optimize immunity against HIV. Here, we summarize the findings reviewed at the workshop and discuss the knowledge gaps and priorities for future studies that will help accelerate the development of a preventive HIV vaccine.
Published in npj Vaccines
ISSN
2059-0105 (Online)
Publisher
Nature Portfolio
Country of publisher
United Kingdom
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website
https://www.nature.com/npjvaccines/
About the journal
WeChat QR code
Close